ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 284 filers reported holding ICU MED INC in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $269 | +52.0% | 1,637 | +44.5% | 0.00% | 0.0% |
| Q4 2022 | $177 | -99.9% | 1,133 | -1.0% | 0.00% | 0.0% |
| Q3 2022 | $171,000 | +1800.0% | 1,144 | +1839.0% | 0.00% | – |
| Q2 2022 | $9,000 | -50.0% | 59 | -27.2% | 0.00% | – |
| Q1 2022 | $18,000 | +125.0% | 81 | +138.2% | 0.00% | – |
| Q4 2021 | $8,000 | +33.3% | 34 | +25.9% | 0.00% | – |
| Q3 2021 | $6,000 | +50.0% | 27 | +28.6% | 0.00% | – |
| Q2 2021 | $4,000 | -60.0% | 21 | -60.4% | 0.00% | – |
| Q1 2021 | $10,000 | – | 53 | +1225.0% | 0.00% | – |
| Q4 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 4 | -84.6% | 0.00% | – |
| Q2 2020 | $5,000 | -37.5% | 26 | -33.3% | 0.00% | – |
| Q1 2020 | $8,000 | +100.0% | 39 | +105.3% | 0.00% | – |
| Q4 2019 | $4,000 | -84.6% | 19 | -88.5% | 0.00% | – |
| Q3 2019 | $26,000 | +85.7% | 165 | +194.6% | 0.00% | – |
| Q2 2019 | $14,000 | -60.0% | 56 | -62.2% | 0.00% | – |
| Q1 2019 | $35,000 | – | 148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |